Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT00997360
What this trial is testing

Study of PKI-179 Administered Orally to Subjects With Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Wyeth is now a wholly owned subsidiary of Pfizer
Early research (Phase 1)Study completedNCT03915379
What this trial is testing

JNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Janssen Research & Development, LLC 68
Testing effectiveness (Phase 2)Study completedNCT00367679
What this trial is testing

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerLung Cancer, Non-Small Cell
GlaxoSmithKline 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT03964727
What this trial is testing

Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumor
Gilead Sciences 227
Testing effectiveness (Phase 2)UnknownNCT04615468
What this trial is testing

TQ-B3525 in Subjects With Relapsed/Refractory Peripheral T-cell Lymphoma（PTCL）

Who this might be right for
Peripheral T-cell Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 78
Early research (Phase 1)UnknownNCT03093168
What this trial is testing

BCMA Chimeric Antigen Receptor Expressing T Cells in Multiple Myeloma

Who this might be right for
Multiple Myeloma
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine 10
Testing effectiveness (Phase 2)Study completedNCT00776074
What this trial is testing

A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.

Who this might be right for
Uterine Fibroids
Takeda 80
Testing effectiveness (Phase 2)Study completedNCT03809013
What this trial is testing

A Open-label, Single-arm, Multicenter, Phase II Study of RC48-ADC to Evaluate the Efficacy and Safety of Subjects With HER2 Overexpressing Locally Advanced or Metastatic Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
RemeGen Co., Ltd. 64
Early research (Phase 1)Looking for participantsNCT06873659
What this trial is testing

SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorGastric CancerLiver Cancer
Qurgen Inc. 96
Early research (Phase 1)Study completedNCT05560360
What this trial is testing

A Trial of DDI Between SHR1459 and Efavirenz With Healthy Subjects

Who this might be right for
B-cell Tumors
Jiangsu HengRui Medicine Co., Ltd. 20
Testing effectiveness (Phase 2)Ended earlyNCT04938180
What this trial is testing

Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients

Who this might be right for
Tenosynovial Giant Cell TumorPigmented Villonodular SynovitisTGCT+1 more
AmMax Bio, Inc. 4
Early research (Phase 1)Ended earlyNCT04480086
What this trial is testing

Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis

Who this might be right for
Myelofibrosis (MF)
AbbVie 1
Testing effectiveness (Phase 2)Looking for participantsNCT07269782
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Henlius Biotech 60
Testing effectiveness (Phase 2)Study completedNCT00130962
What this trial is testing

ALGRX 4975 in the Treatment of Patients With Morton's Neuroma

Who this might be right for
Neuroma
AlgoRx Pharmaceuticals 60
Early research (Phase 1)Study completedNCT02881190
What this trial is testing

Study of RC48-ADC Administered Intravenously to Subjects With HER2-Positive in Advanced Malignant Solid Tumors

Who this might be right for
Solid Tumors
RemeGen Co., Ltd. 57
Testing effectiveness (Phase 2)Study completedNCT00640523
What this trial is testing

Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
BioCryst Pharmaceuticals 23
Testing effectiveness (Phase 2)Ended earlyNCT03646123
What this trial is testing

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Seagen Inc. 255
Testing effectiveness (Phase 2)Ended earlyNCT04525391
What this trial is testing

AZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer

Who this might be right for
SCLC, Recurrent
Se-Hoon Lee 4
Large-scale testing (Phase 3)Study completedNCT00574873
What this trial is testing

Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML

Who this might be right for
Chronic Myeloid Leukemia
Pfizer 502
Testing effectiveness (Phase 2)Ended earlyNCT00061646
What this trial is testing

Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Abbott 25
Next Page